(SBUX) Starbucks - Ratings and Ratios
Coffee, Tea, Beverages, Food, Packaged Goods
Dividends
| Dividend Yield | 2.81% |
| Yield on Cost 5y | 2.70% |
| Yield CAGR 5y | 8.40% |
| Payout Consistency | 68.8% |
| Payout Ratio | 115.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.6% |
| Value at Risk 5%th | 42.7% |
| Relative Tail Risk | -12.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.33 |
| Alpha | -27.71 |
| CAGR/Max DD | -0.08 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.272 |
| Beta | 1.010 |
| Beta Downside | 1.391 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.32% |
| Mean DD | 16.24% |
| Median DD | 15.78% |
Description: SBUX Starbucks December 02, 2025
Starbucks Corporation (NASDAQ:SBUX) is a global coffee roaster, marketer, and retailer that operates through three segments-North America, International, and Channel Development. Its portfolio includes coffee and tea beverages, roasted whole-bean and ground coffee, ready-to-drink drinks, and food items such as pastries and breakfast sandwiches, sold under brands like Starbucks, Teavana, Seattle’s Best, Ethos, and Starbucks Reserve. The company also generates revenue from licensed store concepts and wholesale accounts in grocery and food-service channels.
In FY 2023 Starbucks reported net revenue of approximately $32.5 billion, with comparable-store sales rising about 6 % year-over-year, driven largely by strong performance in its North American and China-focused International segments. Key economic drivers include discretionary consumer spending trends, coffee-bean price volatility, and labor-cost pressures, while the broader restaurant sector faces inflation-sensitive demand and shifting consumer preferences toward premium, experience-based offerings.
For a deeper, data-rich analysis of Starbucks’ valuation and risk profile, consider exploring the detailed metrics and scenario models available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (1.86b TTM) > 0 and > 6% of Revenue (6% = 2.23b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -2.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -7.61% (prev -6.14%; Δ -1.46pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 4.75b > Net Income 1.86b (YES >=105%, WARN >=100%) |
| Net Debt (23.39b) to EBITDA (5.47b) ratio: 4.28 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.72 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.14b) change vs 12m ago 0.32% (target <= -2.0% for YES) |
| Gross Margin 22.90% (prev 26.84%; Δ -3.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 117.4% (prev 115.4%; Δ 1.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.86 (EBITDA TTM 5.47b / Interest Expense TTM 542.6m) >= 6 (WARN >= 3) |
Altman Z'' -0.86
| (A) -0.09 = (Total Current Assets 7.38b - Total Current Liabilities 10.21b) / Total Assets 32.02b |
| (B) -0.26 = Retained Earnings (Balance) -8.27b / Total Assets 32.02b |
| (C) 0.12 = EBIT TTM 3.72b / Avg Total Assets 31.68b |
| (D) -0.22 = Book Value of Equity -8.73b / Total Liabilities 40.11b |
| Total Rating: -0.86 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.61
| 1. Piotroski 3.50pt |
| 2. FCF Yield 2.00% |
| 3. FCF Margin 6.57% |
| 4. Debt/Equity -3.29 |
| 5. Debt/Ebitda 4.28 |
| 6. ROIC - WACC (= -0.64)% |
| 7. RoE -24.05% |
| 8. Rev. Trend 78.94% |
| 9. EPS Trend -43.12% |
What is the price of SBUX shares?
Over the past week, the price has changed by +0.47%, over one month by +8.37%, over three months by +0.56% and over the past year by -11.96%.
Is SBUX a buy, sell or hold?
- Strong Buy: 9
- Buy: 6
- Hold: 18
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the SBUX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 94 | 7.9% |
| Analysts Target Price | 94 | 7.9% |
| ValueRay Target Price | 88.1 | 1.1% |
SBUX Fundamental Data Overview November 29, 2025
P/E Trailing = 53.4417
P/E Forward = 35.3357
P/S = 2.6638
P/EG = 3.0665
Beta = 0.984
Revenue TTM = 37.18b USD
EBIT TTM = 3.72b USD
EBITDA TTM = 5.47b USD
Long Term Debt = 14.58b USD (from longTermDebt, last quarter)
Short Term Debt = 3.06b USD (from shortTermDebt, last quarter)
Debt = 26.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 23.39b USD (from netDebt column, last quarter)
Enterprise Value = 122.20b USD (99.05b + Debt 26.61b - CCE 3.47b)
Interest Coverage Ratio = 6.86 (Ebit TTM 3.72b / Interest Expense TTM 542.6m)
FCF Yield = 2.00% (FCF TTM 2.44b / Enterprise Value 122.20b)
FCF Margin = 6.57% (FCF TTM 2.44b / Revenue TTM 37.18b)
Net Margin = 4.99% (Net Income TTM 1.86b / Revenue TTM 37.18b)
Gross Margin = 22.90% ((Revenue TTM 37.18b - Cost of Revenue TTM 28.67b) / Revenue TTM)
Gross Margin QoQ = 23.11% (prev 22.80%)
Tobins Q-Ratio = 3.82 (Enterprise Value 122.20b / Total Assets 32.02b)
Interest Expense / Debt = 0.55% (Interest Expense 145.8m / Debt 26.61b)
Taxrate = 84.04% (700.6m / 833.7m)
NOPAT = 593.8m (EBIT 3.72b * (1 - 84.04%))
Current Ratio = 0.72 (Total Current Assets 7.38b / Total Current Liabilities 10.21b)
Debt / Equity = -3.29 (negative equity) (Debt 26.61b / totalStockholderEquity, last quarter -8.10b)
Debt / EBITDA = 4.28 (Net Debt 23.39b / EBITDA 5.47b)
Debt / FCF = 9.58 (Net Debt 23.39b / FCF TTM 2.44b)
Total Stockholder Equity = -7.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.80% (Net Income 1.86b / Total Assets 32.02b)
RoE = -24.05% (negative equity) (Net Income TTM 1.86b / Total Stockholder Equity -7.72b)
RoCE = 54.25% (EBIT 3.72b / Capital Employed (Equity -7.72b + L.T.Debt 14.58b))
RoIC = 7.06% (NOPAT 593.8m / Invested Capital 8.41b)
WACC = 7.70% (E(99.05b)/V(125.66b) * Re(9.74%) + D(26.61b)/V(125.66b) * Rd(0.55%) * (1-Tc(0.84)))
Discount Rate = 9.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF Debug] Terminal Value 69.53% ; FCFE base≈2.79b ; Y1≈2.41b ; Y5≈1.90b
Fair Price DCF = 23.13 (DCF Value 26.30b / Shares Outstanding 1.14b; 5y FCF grow -16.70% → 3.0% )
EPS Correlation: -43.12 | EPS CAGR: -8.31% | SUE: -0.77 | # QB: 0
Revenue Correlation: 78.94 | Revenue CAGR: 4.72% | SUE: 0.25 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=-0.045 | Revisions Net=-9 | Analysts=27
EPS current Year (2026-09-30): EPS=2.40 | Chg30d=-0.201 | Revisions Net=-29 | Growth EPS=+12.5% | Growth Revenue=+2.8%
EPS next Year (2027-09-30): EPS=3.02 | Chg30d=-0.228 | Revisions Net=-12 | Growth EPS=+26.2% | Growth Revenue=+7.1%
Additional Sources for SBUX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle